ANI PHARMACEUTICALS INC (ANIP) Stock Cash Flow
NASDAQ:ANIP - Nasdaq - US00182C1036 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -21.05M | -18.52M | 18.78M | -47.90M | -42.60M | |||
| Depreciation Amortization | 75.94M | 67.73M | 59.79M | 59.65M | 47.25M | |||
| Income Taxes - Deferred | -28.40M | -21.91M | -11.74M | -15.25M | -16.75M | |||
| Change In Working Capital | 369.00K | -11.19M | 24.86M | -51.30M | -80.00K | |||
| Interest Paid | 25.33M | 24.38M | 31.43M | 21.48M | 9.71M | |||
| Taxes Paid | 19.63M | 19.06M | 1.23M | 290.00K | 10.37M | |||
| Other non cash items | 53.88M | 47.91M | 27.27M | 23.59M | 15.51M | |||
| OPERATING CASH FLOW | 80.74M | 64.02M | 118.96M | -31.20M | 3.32M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -14.13M | -16.24M | -8.87M | -8.88M | -2.56M | |||
| Other Investing Activity | -419.37M | -388.48M | -9.64M | -6.86M | -102.93M | |||
| INVESTING CASH FLOW | -433.50M | -404.72M | -18.51M | -15.74M | -105.48M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 343.94M | 345.22M | -3.00M | -3.00M | 112.99M | |||
| Stock Issued/Repurchased | -5.87M | -4.47M | 84.56M | -500.00K | 101.18M | |||
| Dividend Paid | -1.63M | -1.63M | -1.63M | -1.63M | -190.00K | |||
| Other Financing Activity | -61.68M | -74.18M | -12.50M | 0.00 | -19.38M | |||
| FINANCING CASH FLOW | 274.76M | 264.94M | 67.44M | -5.13M | 194.60M | |||
| Exchange Rate Effect | N/A | -470.00K | N/A | N/A | N/A | |||
| CHANGE IN CASH | -78.76M | -76.23M | 167.89M | -52.07M | 92.44M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 80.74M | 64.02M | 118.96M | -31.20M | 3.32M | |||
| Capital Expenditure | -14.13M | -16.24M | -8.87M | -8.88M | -2.56M | |||
| FREE CASH FLOW | 66.61M | 47.78M | 110.09M | -40.08M | 760.00K | |||
All data in USD